Atlas Trials

MK0354 Clinical Efficacy and Tolerability Study (0354-004)

Clinical trial NCT00337415 · TERMINATED

Trial details

NCT number
NCT00337415
Sponsor
Merck Sharp & Dohme LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2006-05-01
Primary completion
2006-08-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.